Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Qian, Weia | Shi, Jianhuaa; b | Yin, Xiaomina | Iqbal, Khalidb | Grundke-Iqbal, Ingeb | Gong, Cheng-Xinb; * | Liu, Feia; b; *
Affiliations: [a] Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu, P. R. China | [b] Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY, USA
Correspondence: [*] Correspondence to: Fei Liu or Cheng-Xin Gong, Department of Neurochemistry, New York State Institute for Basic Research, 1050 Forest Hill Road, Staten Island, NY 10314, USA. Tel.: +1 718 494 4820/5248; Fax: +1 718 494 1080; E-mail: [email protected] (F. Liu) or [email protected] (C.X. Gong).
Abstract: Abnormal hyperphosphorylation of tau appears to be crucial in neurofibrillary degeneration in Alzheimer's disease (AD). Previous studies suggest that a down-regulation of protein phosphatase 2A (PP2A), the major tau phosphatase in human brain, contributes to tau hyperphosphorylation in AD. However, the effects of PP2A down-regulation on site-specific tau hyperphosphorylation is not well understood. In the present study, we showed that PP2A dephosphorylated tau at several phosphorylation sites with different efficiencies. Among the sites studied, Thr205, Thr212, Ser214, and Ser262 were the most favorable sites, and Ser199 and Ser404 were the least favorable sites for PP2A in vitro. Inhibition of PP2A with okadaic acid in metabolically active rat brain slices caused inhibition of glycogen synthase kinase-3β (GSK-3β) via an increase in its phosphorylation at Ser9. GSK-3β phosphorylated tau at many sites, with Ser199, Thr205, and Ser396 being the most favorable sites in cells. The overall alterations in tau phosphorylation induced by PP2A inhibition were the result of the combined effects of both reduced tau dephosphorylation due to PP2A inhibition directly and reduced phosphorylation by GSK-3β due to its inhibition. Because the impacts of tau phosphorylation on its biological activity and on neurofibrillary degeneration are site-specific, this study provides a new insight into the role of PP2A down-regulation in neurofibrillary degeneration in AD.
Keywords: GSK-3β, phosphorylation, PP2A, tau
DOI: 10.3233/JAD-2010-1317
Journal: Journal of Alzheimer's Disease, vol. 19, no. 4, pp. 1221-1229, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]